|
Jul 30
|
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain
|
|
Jul 30
|
BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
|
|
Jul 29
|
Vertex (VRTX) Stock Before Q2 Earnings: To Buy or Not to Buy?
|
|
Jul 29
|
Curious about Vertex (VRTX) Q2 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Jul 28
|
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
|
|
Jul 26
|
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
|
Jul 25
|
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic
|
|
Jul 25
|
Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact
|
|
Jul 25
|
Is Vertex Pharmaceuticals' Monopoly in Danger?
|
|
Jul 24
|
Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
|
|
Jul 24
|
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
|
|
Jul 24
|
Exploring Undervalued Stocks On US Exchanges With Discounts Ranging From 21.1% To 38.5%
|
|
Jul 24
|
Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics
|
|
Jul 23
|
7 Biotech Stocks to Keep on Your Clinical Radar
|
|
Jul 23
|
HHS gives thumbs down to bluebird’s fertility support programme
|
|
Jul 23
|
Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?
|
|
Jun 25
|
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
|
|
Jun 24
|
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong Financial Performance in Q1
|
|
Jun 24
|
Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial
|
|
Jun 21
|
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions
|